Pnc Financial Services Group, Inc. Harvard Bioscience Inc Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 7,921 shares of HBIO stock, worth $2,613. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,921
Previous 5,179
52.94%
Holding current value
$2,613
Previous $10,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
26.2MCall Options Held
8.7KPut Options Held
2K-
Amh Equity LTD3.39MShares$1.12 Million3.14% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$938,4040.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$721,8750.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$705,7870.0% of portfolio
-
Royce & Associates LP1.78MShares$586,7050.01% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $13.7M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...